J&J’s Acquisition, Research, Women’s Health: The Week in Health

Johnson & Johnson acquired Ambrx Biopharma with the aim of advancing the development of next-generation antibody drug conjugates. Meanwhile, scientific research in the fields of cardiovascular conditions and Peripheral Arterial Disease is advancing. Moreover, women's health remains a top priority, with a focus on cervical cancer and oral health.

The Week in Health:

J&J Acquires Ambrx Biopharma

Johnson & Johnson (J&J) has finalized the acquisition of Ambrx Biopharma, a clinical-stage biopharmaceutical company specializing in next-generation antibody drug conjugates. The acquisition, valued at approximately US$2 billion in total equity, marks a significant move for J&J as it expands its portfolio in cancer treatment. Read the whole story here. 

Diet Sodas and Sweeteners: A 20% Increase in A-fib Risk

The recently published study, Artificial Sweeteners: A New Dietary Environmental Risk, reveals a concerning link between the consumption of artificially sweetened beverages and a 20% increase in the risk of developing an irregular heartbeat, or Atrial Fibrillation (A-fib). In the sixth highest soda-consuming country, Mexico, government data underscores a significant clinical and economic burden for the country. Learn more about it here.

BD Study: Testing the Effectiveness of Stents in PAD Treatment

Becton, Dickinson and Company (BD), a medical technology company, announced the initiation of its “AGILITY” study, marking a significant advancement in the fight against Peripheral Arterial Disease (PAD). Through this study, BD aims to test its investigational device exemption (IDE) to evaluate the safety and effectiveness of the BD Vascular Covered Stent for treating PAD. Read the whole story here.

Global Commitment: US$600M Pledged to Eradicate Cervical Cancer

To eradicate cervical cancer globally, governments, donors, and partners have committed nearly US$600 million to the Global Cervical Cancer Elimination Forum in Colombia. The funding will facilitate the expansion of comprehensive prevention programs, address disruptions caused by COVID-19, and implement a one-dose HPV vaccine strategy. Read the whole story here. 

Recognizing Women's Specific Oral Health Needs

Oral health is a critical yet often overlooked aspect of holistic well-being, especially among women. Women have specific oral health needs that evolve with each stage of their lives. However, a general lack of health insurance coverage and the responsibility of contraceptive use can present barriers to women achieving optimal oral health, according to a study. To bridge this disparity,  it is essential to have a healthcare sector that is sensitive to gender considerations to effectively address these concerns. Learn more about it here.